United States· US:49643-117_36ad1e17-751d-e226-e063-6394a90ab328
Pullularia
A medicinal product containing aureobasidium pullulans var. pullutans, registered in United States by Allermed Laboratories, Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- AUREOBASIDIUM PULLULANS VAR. PULLUTANS
- Manufacturer
- Allermed Laboratories, Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 8
- ndc1149643117055 mL in 1 VIAL, MULTI-DOSE (49643-117-05)
- ndc11496431171010 mL in 1 VIAL, MULTI-DOSE (49643-117-10)
- ndc11496431173030 mL in 1 VIAL, MULTI-DOSE (49643-117-30)
- ndc11496431175050 mL in 1 VIAL, MULTI-DOSE (49643-117-50)
- ndc1149643-117-05
- ndc1149643-117-10
- ndc1149643-117-30
- ndc1149643-117-50
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Aureobasidium pullulans var. pullutans in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- GermanyPrick-Testlösung Pullularia PullulansAllergopharma Gmbh & Co. Kg
- SwitzerlandPrick-Test Pullularia pullulans, PricktestlösungDermapharm AG
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Germany · Prick-Testlösung Pullularia Pullulans, Provokations-Testlösung Pullularia Pullulans
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bd09190b-487d-4f6b-9cdb-4bf1faa2b19a GET /v1/drugs/bd09190b-487d-4f6b-9cdb-4bf1faa2b19a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "CUTANEOUS; INTRADERMAL; SUBCUTANEOUS",
"source": "ndc",
"strength": ".01",
"substance": "AUREOBASIDIUM PULLULANS VAR. PULLUTANS",
"productndc": "49643-117",
"dosage_form": "INJECTION",
"dea_schedule": null,
"strength_unit": "g/mL",
"application_number": "BLA102211",
"marketing_category": "BLA"
}See everything about aureobasidium pullulans var. pullutans.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.